Skip to content
  • About us
          • About us
          • Catalog Biofarm 100
          • History
          • Mission Vision Values
          • Code of Ethics and Organisational conduct
          • Certification
          • Export
          • Quality Assurance
          • Internal market
          • Production facilities
          • Biofarm brands
          • R&D Development
          • Environmental protection
          • Pharmacovigilance
  • Products
          • Product list
          • Product catalogue
  • Corporate Governance/Investor Relations
          • General Information
          • Financial calendar
          • Current reports
          • Press realeases
          • Non-Financial Reporting/ESG
          • Financial statements and presentations for investors
          • Public Tender of Procurement
          • GMS
          • Procedure for the payment of dividends
          • Analysts Coverage
          • Articles of incorporation
          • Code of Ethics and Organisational Conduct
          • Policies
          • Regulations and Consultative Committees Regulations
          • Statement of Compliance
          • The Board of Directors and the Management Disclosure
          • Transactions of persons with management responsibilities and persons in close relations
          • Information note on the protection of personal data
          • info BVB
          • Share price
          • FAQ
  • Careers
  • News
  • Contact
  • ro

Press realeases

Home / Corporate Governance/Investor Relations / Press realeases

2025

  • 2025-05-13 Communique
  • 2025-04-28 Communique
  • 2025-02-28 Communique

2024

  • 2024-11-13 Communique
  • 2024-08-21 Communique
  • 2024-05-13 Communique
  • 2024-04-24 Communique
  • 2024-02-27 Communique

2023

  • 2023-11-14 Communique
  • 2023-08-10 Communique
  • 2023-05-11 Communique
  • 2023-04-26 Communique
  • 2023-03-06 Communique External auditor selection procedure
  • 2023-02-24 Communique

2022

  • 2022-11-11 Communique
  • 2022-08-11 Communique
  • 2022-05-12 Communique
  • 2022-02-24 Communique

2021

  • 2021-11-15 Communique
  • 2021-08-12 Communique
  • 2021-05-13 Communique
  • 2021-02-15 Communique

2020

  • Press Release – financial statements for the 3rd quarter of 2020
  • 2020-11-12 Communique
  • Press Release – financial statements for the 1st semester of 2020
  • 2020-08-12 Communique
  • 2020-08-12 Communique
  • 2020-05-13 Communique
  • 2020-04-28 Communique
  • 2020-03-24 Announcement regarding ongoing activity in the context COVID-19
  • 2020-03-24 Communique GMS carrying in the context of SARS-CoV-2
  • 2020-02-14 Communique

2019

  • 2019-11-13 Communique
  • 2019-08-12 Communique
  • 2019-05-14 Communique
  • 2019-02-13 Communique

2018

  • 2018-11-09 Communique
  • 2018-08-14 Communique
  • 2018-05-11 Communique
  • 2018-04-19 Communique
  • 2018-01-30 Communique

2017

  • 2017-11-02 Availability Communique
  • 2017-11-02 Communique
  • 2017-08-10 Communique
  • 2017-05-12 Communique
  • 2017-04-26 Communique
  • 2017-02-14 Communique

2016

  • 2016-12-21 Communique Biofarm’s financial reporting calendar for 2017
  • 2016-11-14 Communique
  • 2016-08-11 Communique
  • 2016-05-12 Communique
  • 2016-05-11 Communique
  • 2016-04-29 Communique
  • 2016-03-24 Press release
  • 2016-02-15 Communique
  • 2016-01-07 Communique Biofarm’s financial reporting calendar for 2016

2015

  • 2015-11-11 Communique
  • 2015-08-12 Communique
  • 2015-05-14 Communique
  • 2015-04-23 Communique
  • 2015-02-12 Communique
  • 2015-01-29 Communique
  • 2015-01-21 Communique

2014

  • 2014-11-14 Press Release
  • 2014-08-14 Communique
  • 2014-05-14 Communique
  • 2014-04-17 Communique
  • 2014-02-14 Communique

2013

  • 2013-12-16 Communique
  • 2013-11-11 Communique
  • 2013-10-16 Communique regarding the procedure for the distribution of dividents in 2011
  • 2013-08-14 Communique
  • 2013-06-04 Press release – Official Statement – Distribution of 2012 Dividends
  • 2013-05-14 Communique
  • 2013-04-18 Communique
  • 2013-03-14 Communique
  • 2013-02-15 Communique

2012

  • 2012-11-14 Communique
  • 2012-10-11 Communique regarding the procedure for the distribution of dividents in 2011
  • 2012-08-15 Communique
  • 2012-06-27 Communique – Communique regarding the procedure for the distribution of dividents in 2010
  • 2012-06-12 Communique
  • 2012-05-15 Communique
  • 2012-04-24 Communique
  • 2012-02-16 Communique

2011

  • 2011-11-14 Communique
  • 2011-09-30 Communique
  • 2011-08-12 Press release – Availability non-audited Financial Statements Semester I 2011
  • 2011-07-25 Notification
  • 2011-05-16 Notification – Availability non-audited Financial Statements Quarter 1 2011
  • 2011-04-21 Press release – Availability Audited Annual Financial Statements 2010
  • 2011-02-15 Press release – Non-audited Financial Statements 31-12-2010

2010

  • 2010-11-12 Communique
  • 2010-11-12 Notification
  • 2010-08-13 Communique
  • 2010-08-13 Press Release
  • 2010-05-14 Communique
  • 2010-05-14 Press Release
  • 2010-04-21 Communique
  • 2010-04-01 Communique
  • 2010-02-12 Communique

2009

  • 2009-11-12 Press Release on the financial results for the first 9 months of 2009
  • 2009-11-12 Communique
  • 2009-08-14 Communique
  • 2009-08-14 Press Release
  • 2009-05-14 Press Release regarding the financial results of the first quarter of 2009
  • 2009-05-14 Communique
  • 2009-04-16 Communique
  • 2009-02-13 Communique

    About Biofarm

    • About us
    • History
    • Mission Vision Values
    • Environmental protection
    • Research & Development capacities

    Info

    • ANPC
    • European Online Dispute Resolution
    • Pharmacovigilance
    • Whistleblowers

    Legal

    • Cookie policy
    • Terms and conditions
    • Privacy Policy
    • Data Protection

    Cariere

    • Team
    • Available jobs
    Biofarm

    SOCIETATEA BIOFARM S.A., cu sediul in Bucuresti, Str. Logofatul Tautu nr. 99, sector 3, înmatriculată la Registrul Comertului J1991000199407, Cod Unic de Inregistrare RO 341563

    COOKIE SETTINGS